P. Borrachero et al. / Tetrahedron: Asymmetry 13 (2002) 2025–2038
2033
127.9, 127.5, 126.9 (2Ph), 112.8 (CMe2), 104.1 (C-1%),
5.5. Reaction of (2R,3R,5S)-2-benzyl-3-(1,2:3,4-di-O-
80.7 (C-4%), 78.6 (C-2%), 78.5 (C-3%), 71.8 (O-CH2Ph),
67.1 (C-5), 66.7 (C-3), 61.9 (N-CH2Ph), 34.9 (C-4),
26.9, 26.8 (CMe2), and −3.7 (SiMe3); HRCIMS: m/z
483.2437 (calcd for C27H36NO5Si: 483.2441).
isopropylidene-a-D-galacto-pentopyranos-5-yl)-5-
(trimethylsilyl)isoxazolidine, 5a with acetyl chloride:
preparation of 6-(N-benzyl)acetamido-6,7-dideoxy-
1,2:3,4-di-O-isopropylidene-
D
-glycero-a- -galacto-octo-
D
dialdo-1,5-pyranose, 8 and (E)-6,7-didehydro-6,7-
Compound 7a: oil; Rf 0.33 (6:1 hexane:ethyl acetate);
[h]2D3=+101 (c 1.8, CH2Cl2); IR (KBr) wmax 1377
(CMe2), 1252 (lC–H of SiCH3), and 737 cm−1 (wSi–C);
1H NMR (300 MHz, CDCl3) l 7.36–7.26 (m, 10H,
2Ph), 5.69 (d, 1H, J1%,2%=3.7, H-1%), 4.77, 4.53 (each d,
dideoxy-1,2:3,4-di-O-isopropylidene-a- -galacto-
octodialdo-1,5-pyranose, 9
D
A suspension of 5a (0.19 g, 0.41 mmol) and sodium
hydrogen carbonate (0.115 g) in freshly distilled tetra-
hydrofuran (5 mL) was cooled at 0°C and treated with
acetyl chloride (0.43 mL, 0.61 mmol) under argon. The
mixture was maintained at 0°C for 3 h (TLC monitor-
ing, 6:1 and 1:1 hexane:ethyl acetate), and the reaction
was quenched by adding saturated aqueous sodium
hydrogen carbonate until neutral pH. The mixture was
extracted with ether (3×25 mL), and the combined
ethereal layers were dried (MgSO4) and concentrated to
give a crude product, purification of which was
achieved by column chromatography (6:11:1 gradi-
ent, hexane:ethyl acetate), to afford unreacted 5a (36
mg, indicating 81% of conversion), compound 8 (37
mg, 21%, corresponding to 26% yield from converted
substrate), and compound 9 (46 mg, 39%, correspond-
ing to ꢀ49% from converted substrate). Compound 8:
syrup; Rf 0.67 (1:1 hexane:ethyl acetate); [h]2D3=−10 (c
0.68, CH2Cl2); IR (KBr) wmax 1717 (aldehyde CꢁO),
1653 (amide CꢁO), and 1383 cm−1 (CMe2); HREIMS:
m/z 433.2091 (calcd for C23H31NO7: 433.2101),
418.1849 (calcd for C23H31NO7–CH3: 418.1866); major
amide conformer (62.5%): 1H NMR (500 MHz, CDCl3)
l 9.39 (dd, 1H, JCHO,7a=2.3, JCHO,7b=2.0, CHO), 7.35–
7.14 (m, 5H, Ph), 5.48 (d, 1H, J1,2=5.2, H-1), 4.71, 4.55
(each d, each 1H, Jgem=16.6, CH2Ph), 4.30–4.25 (over-
each 1H, Jgem=11.4, O-CH2Ph), 4.59 (dd, 1H, J2%,3%
=
4.1, H-2%), 4.23 (dd, 1H, J3%,4%=8.6, J3,4%=2.8, H-4%),
4.15, 3.93 (each d, each 1H, Jgem=14.0, N-CH2Ph), 4.11
(dd, 1H, H-3%), 3.48 (dd, 1H, J4a,5=7.0, J4b,5=11.7,
H-5), 3.17 (ddd, 1H, J3,4a=4.2, J3,4b=10.3, H-3), 2.33
(ddd, 1H, J4a,4b=11.6, H-4a), 1.92 (ddd, 1H, H-4b),
1.57, 1.37 (each s, each 3H, CMe2), and 0.02 (s, 9H,
SiMe3); NOE contacts (1D NOESY): H-3, H-4%, H-3%,
N-CH2-Ph; H-5, H-3%, N-CHHPh, H-4a; 13C NMR
(75.5 MHz, CDCl3) l 137.5, 129.7, 128.2, 127.9, 127.8,
126.7 (2Ph), 112.8 (CMe2), 103.7 (C-1%), 79.2 (C-4%),
78.6 (C-3%), 77.6 (C-2%), 71.9 (O-CH2Ph), 69.5 (C-5),
63.7 (C-3), 62.2 (N-CH2Ph), 33.6 (C-4), 26.7, 26.6
(CMe2), and −3.9 (SiMe3); HRCIMS: m/z 483.2429
(calcd for C27H36NO5Si: 483.2441).
Isomer mixture (7b+7d): oil; Rf=0.22 (6:1 hexane:ethyl
acetate); IR (KBr) wmax 1377 (CMe2), 1254 (lC–H of
SiCH3), and 741 cm−1 (wSi–C); HRCIMS: m/z 483.2438
(calcd for C27H36NO5Si: 483.2441); the NMR spectra
showed signals for two isomers in a 4:1 ratio; for the
major component: 1H NMR (300 MHz, CDCl3) l
7.33–7.24 (m, 10H, 2Ph), 5.83 (d, 1H, J1%,2%=3.9, H-1%),
4.52, 4.14 (each d, each 1H, Jgem=11.4, O-CH2Ph), 4.51
(dd, 1H, J2%,3%=4.4, H-2%), 4.00 (dd, 1H, J3,4%=3.9,
lapped signal, 1H, H-6), 4.51 (dd, 1H, J2,3=2.3, J3,4
=
J3%,4%=8.9, H-4%), 3.92, 3.84 (each d, each 1H, Jgem
=
8.1, H-3), 4.29 (dd, 1H, J1,2=4.8, J2,3=2.3, H-2), 4.23
(dd, 1H, J3,4=7.9, J4,5=1.7, H-4), 4.60–4.50 (over-
lapped, H-5), 2.98 (ddd, 1H, J7a,7b=17.0, J6,7a=5.6,
13.1, N-CH2Ph), 3.72 (dd, 1H, J4a,5=6.4, J4b,5=9.5,
H-5), 3.64 (dd, 1H, H-3%), 3.15 (ddd, 1H, J3,4a=2.5,
J3,4b=9.0, H-3), 2.33 (ddd, 1H, J4a,4b=12.0, H-4a), 2.10
J7a,CHO=2.5, H-7a), 2.67 (ddd, 1H, J7a,7b=17.0, J6,7b=
(ddd, 1H, H-4b), 1.57, 1.35 (each s, each 3H, CMe2),
and 0.04 (s, 9H, SiMe3); 13C NMR (75.5 MHz, CDCl3)
l 137.3, 137.2, 130.0, 128.1, 128.0, 127.9, 127.8, 127.7
(2Ph), 112.5 (CMe2), 104.3 (C-1%), 80.7 (C-4%)), 79.1
(C-3%), 76.5 (C-2%), 71.6 (O-H2Ph), 70.4 (C-5), 63.5
(N-H2Ph), 63.3 (C-3), 34.8 (C-4), 26.6, 26.5 (CMe2),
5.7, J7b,CHO=1.6, H-7b), 2.16 (s, 3H, Me–CꢁO), [1.55
(s, 3H), 1.45 (s, 6H), and 1.32 (s, 3H) 2CMe2]; 13C
NMR (125.7 MHz, CDCl3) l 200.4 (CHO), 171.7 (N-
OCH3), 136.7, 128.9, 128.6, 127.9, 127.4, 127.3 (Ph),
109.4, 109.1 (2CMe2), 96.7 (C-1), 71.1 (C-3), 70.9 (C-4),
70.7 (C-2), 69.0 (C-5), 54.2 (C-6), 54.2 (CH2Ph), 44.6
(C-7), 29.7, 26.0 (each double intensity, 2CMe2), and
1
and −3.8 (SiMe3); for the minor component: H NMR
1
(300 MHz, CDCl3) l 7.33–7.24 (m, 10H, 2Ph), 5.81 (d,
overlapped with the signal for the respective proton of
the major component, 1H, J1%,2%:4.1, H-1%), 4.54, 4.12
(each d, each 1H, Jgem=11.3, O-H2Ph), 4.51 (dd, 1H,
J2%,3%=4.1, H-2%), 3.94 (dd, 1H, J3,4%=3.8, J3%,4%=8.7,
H-4%), 3.92, 3.84 (each d, each 1H, Jgem=13.1, N-H2Ph),
3.71 (dd, 1H, J4a,5=6.6, J4b,5=12.2, H-5), 3.63 (dd, 1H,
H-3%), 3.26 (ddd, 1H, J3,4a=8.3, J3,4b=6.7, H-3), 2.44
(ddd, 1H, J4a,4b=11.8, H-4a), 2.24 (ddd, 1H, H-4b),
1.56, 1.27 (each s, each 3H, CMe2), and 0.06 (s, 9H,
SiMe3); 13C NMR (75.5 MHz, CDCl3) l 137.5, 137.3,
130.0, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7 (2Ph),
112.2 (CMe2), 104.1 (C-1%), 79.9 (C-4%)), 79.4 (C-3%),
76.5 (C-2%), 71.5 (O-CH2Ph), 67.4 (C-5), 64.9 (N-
CH2Ph), 61.1 (C-3), 35.1 (C-4), 29.5, 26.6 (CMe2), and
−3.7 (SiMe3).
23.1 (Me–CO–N); minor amide conformer (37.5%): H
NMR (500 MHz, CDCl3) l 9.33 (br s, 1H, CHO),
7.35–7.14 (m, 5H, Ph), 5.49 (d, 1H, J1,2=5.1, H-1),
5.05, 4.06 (each d, each 1H, Jgem=15.7, CH2Ph), 4.65
(m, 1H, H-6), 4.50 (dd, 1H, J2,3=2.4, J3,4=7.9, H-3),
4.29 (dd, 1H, J1,2=4.8, J2,3=2.3, H-2), 4.01 (dd, 1H,
J3,4=8.0, J4,5=1.5, H-4), 3.86 (dd, 1H, J4,5=1.2, J5,6=
10.2, H-5), 2.92 (dd, 1H, J7a,7b=18.1, J6,7a=4.1, H-7a),
2.60 (dd, 1H, J7a,7b=18.1, J6,7b=9.0, H-7b), 2.49 (s, 3H,
Me–CꢁO), 1.42, 1.41, 1.34, and 1.32 (each s, each 3H,
2CMe2); 13C NMR (125.7 MHz, CDCl3) l 199.3
(CHO), 172.9 (N-COCH3), 138.5, 128.9, 128.6, 127.9,
127.4, 127.3 (Ph), 109.5, 108.7 (2CMe2), 96.7 (C-1),
71.0 (C-3), 70.7 (C-2), 70.1 (C-4), 67.8 (C-5), 52.5 (C-6),
45.3 (CH2Ph), 44.9 (C-7), 25.1, 24.8, 24.5, 24.3
(2CMe2), and 21.9 (Me–CO–N). Compound 9: syrup;